Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.
05:24pm, Monday, 04'th Oct 2021
New York, New York--(Newsfile Corp. - October 4, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Cassava Sciences
New York, New York--(Newsfile Corp. - October 4, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA) al
Los Angeles, California--(Newsfile Corp. - October 4, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cassava Scienc
New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
Use Cassava Sciences Stock Weakness as Buy Opportunity Ahead of Phase 3
06:00am, Monday, 04'th Oct 2021
If Cassava Sciences' Alzheimer drug can continue to produce solid results, it could see FDA approval before the end of 2022. SAVA stock may not be oversold for long.
What to Make of Cassava Sciences' Late September Rally
06:00am, Monday, 04'th Oct 2021
Cassava Sciences gained 50% in the second half of September. Now the question is, can SAVA stock keep up momentum in October?
Cassava Class Action Reminder
08:27am, Sunday, 03'rd Oct 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cassava To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Co
New York, New York--(Newsfile Corp. - October 2, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA)
Radnor, Pennsylvania--(Newsfile Corp. - October 2, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors of Cassava Sciences, Inc. (NASDAQ: SAVA) ("Cassava") that a securities fr
New York, New York--(Newsfile Corp. - October 1, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA) a
San Francisco, California--(Newsfile Corp. - October 1, 2021) - Hagens Berman urges Cassava Sciences, Inc. (NASDAQ: SAVA) investors with significant losses to submit your losses now. Class Period: Se
Cassava Stock Has Reached a Positive Turning Point
10:55am, Friday, 01'st Oct 2021
Cassava is rebounding and SAVA stock may rally back to its old highs as it fends off a short-selling attack. The post Cassava Stock Has Reached a Positive Turning Point appeared first on InvestorPlace
The Good News Is Piling Up for Cassava Stock
06:00am, Friday, 01'st Oct 2021
Recent news indicates that the FDA is going to reject a petition against Cassava, helping to make SAVA stock very attractive. The post The Good News Is Piling Up for Cassava Stock appeared first on In
SAVA LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of Cassava Sciences, Inc. Shareholders
05:28am, Friday, 01'st Oct 2021
New York, New York--(Newsfile Corp. - October 1, 2021) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Cassava Sciences, Inc. (NASDAQ
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PHG, ATIP and SAVA
07:05pm, Thursday, 30'th Sep 2021
NEW YORK, NY / ACCESSWIRE / September 30, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded compani
